Risk factors for advanced duodenal and ampullary adenomatosis in familial adenomatous polyposis: a prospective, single-center study

Carregando...
Imagem de Miniatura
Citações na Scopus
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
GEORG THIEME VERLAG KG
Citação
ENDOSCOPY INTERNATIONAL OPEN, v.6, n.5, p.E531-E540, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background and study aims To determine the clinical features associated with advanced duodenal and ampullary adenomas in familial adenomatous polyposis. Secondarily, we describe the prevalence and clinical significance of jejunal polyposis. Patients and methods This is a single center, prospective study of 62 patients with familial adenomatous polyposis. Duodenal polyposis was classified according to Spigelman and ampullary adenomas were identified. Patients with Spigelman III and IV duodenal polyposis underwent balloon assisted enteroscopy. Predefined groups according to Spigelman and presence or not of ampullary adenomas were related to the clinical variables: gender, age, family history of familial adenomatous polyposis, type of colorectal surgery, and type of colorectal polyposis. Results Advanced duodenal polyposis was present in 13 patients (21%; 9 male) at a mean age of 37.61 +/- 13.9 years. There was a statistically significant association between family history of the disease and groups according to Spigelman (P=0.03). Seven unrelated patients (6 male) presented ampullary adenomas at a mean age of 36.14 +/- 14.2 years. The association between ampullary adenomas and extraintestinal manifestations was statistically significant in multivariate analysis (P=0.009). Five endoscopic types of non-ampullary adenoma were identified, showing that lesions larger than 10mm or with a central depression presented foci of high grade dysplasia. Among 28 patients in 12 different families, a similar Spigelman score was identified; 10/12 patients (83.3%) who underwent enteroscopy presented small tubular adenomas with low grade dysplasia in the proximal jejunum. Conclusions Advanced duodenal polyposis phenotype may be predictable from disease severity in a first-degree relative. Ampullary adenomas were independently associated with the presence of extraintestinal manifestations.
Palavras-chave
Referências
  1. Alderlieste YA, 2013, FAM CANCER, V12, P51, DOI 10.1007/s10689-012-9571-1
  2. ARVANITIS ML, 1990, DIS COLON RECTUM, V33, P639, DOI 10.1007/BF02150736
  3. Balmana J, 2013, ANN ONCOL, V24, P73, DOI 10.1093/annonc/mdt209
  4. BISGAARD ML, 1994, HUM MUTAT, V3, P121, DOI 10.1002/humu.1380030206
  5. Campos FG, 2015, WORLD J GASTROINTEST, V7, P950, DOI 10.4253/wjge.v7.i10.950
  6. Cappel WHDTN, 2003, BRIT J SURG, V90, P705, DOI 10.1002/bjs.4094
  7. CHURCH JM, 1992, DIS COLON RECTUM, V35, P1170, DOI 10.1007/BF02251971
  8. de Campos FGCM, 2010, J GASTROINTEST SURG, V14, P1943, DOI 10.1007/s11605-010-1288-6
  9. Dekker E, 2009, ENDOSCOPY, V41, P666, DOI 10.1055/s-0029-1214980
  10. Drini M, 2012, FAM CANCER, V11, P167, DOI 10.1007/s10689-011-9496-0
  11. Groves CJ, 2002, GUT, V50, P636, DOI 10.1136/gut.50.5.636
  12. Iaquinto G, 2008, GASTROINTEST ENDOSC, V67, P61, DOI 10.1016/j.gie.2007.07.048
  13. Jaganmohan S, 2012, DIGEST DIS SCI, V57, P732, DOI 10.1007/s10620-011-1917-2
  14. JAGELMAN DG, 1988, LANCET, V1, P1149
  15. Latchford AR, 2009, CLIN GASTROENTEROL H, V7, P659, DOI 10.1016/j.cgh.2009.02.028
  16. Lopez-Ceron M, 2013, GASTROINTEST ENDOSC, V77, P542, DOI 10.1016/j.gie.2012.11.033
  17. Mathus-Vliegen EMH, 2011, CLIN GASTROENTEROL H, V9, P279, DOI 10.1016/j.cgh.2010.12.011
  18. Monkemuller K, 2007, ENDOSCOPY, V39, P52, DOI 10.1055/s-2006-945116
  19. Picasso M, 2007, DIGEST DIS SCI, V52, P1906, DOI 10.1007/s10620-006-9653-8
  20. Pittayanon R, 2015, ENDOSC INT OPEN, V3, pE450, DOI 10.1055/s-0034-1392235
  21. RUSTIN RB, 1990, DIS COLON RECTUM, V33, P52, DOI 10.1007/BF02053203
  22. Sanabria JR, 1996, AM J SURG, V171, P136, DOI 10.1016/S0002-9610(99)80088-9
  23. Saurin JC, 2002, GASTROINTEST ENDOSC, V55, P342, DOI 10.1067/mge.2002.121882
  24. Saurin JC, 2015, ENDOSC INT OPEN, V3, pE456, DOI 10.1055/s-0034-1393130
  25. Saurin LC, 2004, J CLIN ONCOL, V22, P493
  26. Schlemper RJ, 2000, GUT, V47, P251, DOI 10.1136/gut.47.2.251
  27. SPIGELMAN AD, 1989, LANCET, V2, P783
  28. Sulbaran M, 2016, ENDOSC INT OPEN, V4, pE151, DOI 10.1055/s-0041-108261
  29. Vasen HFA, 2008, GUT, V57, DOI 10.1136/gut.2007.136127
  30. Wong RF, 2006, GASTROINTEST ENDOSC, V64, P530, DOI 10.1016/j.gie.2005.12.014